SOUTH SAN FRANCISCO, Calif., May 15, 2026
FDB (First Databank) announced new research findings at the AMIA Amplify Informatics Conference 2026 showing that a patient-specific medication guidance approach reduced pharmacy alert volumes by nearly 70% in a high-volume community pharmacy environment. The study highlights how intelligent consolidation of medication safety alerts can reduce pharmacist alert fatigue, improve workflow efficiency, and create more time for direct patient care. The findings were presented by clinical informatics pharmacists from FDB during the conference poster session focused on advanced clinical decision support (CDS) technologies.
The research evaluated how pharmacists interact with medication alerts across multiple clinical domains, including drug-drug interactions, duplicate therapy warnings, dosing concerns, contraindications, and specialty population precautions. Traditionally, pharmacists receive fragmented alerts separately across these categories, creating cognitive overload and increasing the risk that critical safety signals may be overlooked. FDB’s redesigned CDS framework instead consolidates alerts into a single patient-specific risk message that identifies the most clinically relevant concern and provides recommended next-step actions for pharmacists.
Patient-Specific Alert Strategy Improves Pharmacy Workflow
According to the study, pharmacists in traditional community pharmacy environments received an average of 241.5 alerts per 250 prescriptions. After implementation of FDB’s consolidated risk-based alert system, the number of alerts dropped to fewer than 50 alerts per 250 prescriptions, representing a dramatic 70% reduction in alert burden. Researchers stated that this reduction was achieved without compromising patient safety or clinical rigor.
FDB’s approach uses a proprietary API to map multiple medication warnings to a single primary clinical outcome called a “Clinical Consequence.” Alerts connected to the same risk are grouped together into one actionable “Risk of” message, helping pharmacists prioritize patient care decisions more effectively. The system also includes advanced intelligent alert management capabilities such as repeat-alert suppression, ICD-10-CM expiration logic for acute conditions, and patient-specific risk escalation or downgrading based on clinical factors.
Usha Desiraju, PharmD, manager of informatics and clinical content at FDB, stated that the redesigned CDS model aligns medication safety tools with real-world pharmacist workflows. She emphasized that community pharmacists are handling increasing responsibilities while simultaneously facing overwhelming alert volumes that can undermine medication safety goals. By surfacing only the highest-priority patient-specific risks, pharmacists can focus on meaningful interventions rather than reviewing repetitive warnings.
Advertisement
FDB Navigo Platform Supports Next-Generation Medication Guidance
The new CDS methodology is delivered through FDB Navigo™, a web-based API platform designed to modernize medication decision support systems. Unlike traditional severity-based alert systems, Navigo provides consolidated, risk-focused guidance aligned with clinical workflows and patient-specific context. Researchers reported that pharmacists accepted more than 75% of the system’s recommended next-best actions, indicating strong confidence in the relevance and usefulness of the alerts.
Michael T. Silver, PharmD, clinical informatics pharmacist at FDB, noted that the study demonstrated how reorganizing clinical knowledge into more meaningful patient-specific guidance significantly improved pharmacist trust and efficiency. When pharmacists believe alerts accurately represent the highest-priority risks for a patient, they can respond faster and dedicate more time to patient counseling and care coordination.
The findings arrive at a time when community pharmacists are taking on expanded clinical responsibilities such as vaccinations, preventive screenings, medication therapy management, and chronic disease monitoring. As healthcare systems increasingly rely on digital clinical decision support tools, reducing unnecessary alert burden has become a major operational priority. Industry experts believe intelligent CDS platforms like FDB Navigo could play a significant role in improving medication safety while reducing burnout among pharmacists and healthcare providers.
Growing Demand for Smarter Clinical Decision Support
Healthcare organizations continue to face growing pressure to balance patient safety with workflow efficiency. Excessive alerts in pharmacy systems have long been associated with alert fatigue, a condition where clinicians become desensitized to warnings due to excessive frequency. Studies have shown that poorly designed alert systems can contribute to ignored warnings, workflow disruption, and clinician burnout.
FDB’s research demonstrates how patient-specific, consolidated guidance models may represent the next evolution of medication safety technology. By integrating structured clinical intelligence with practical workflow optimization, advanced CDS systems could help pharmacies deliver more efficient, accurate, and patient-centered care while improving operational consistency across large pharmacy networks.
Source: FDB press release
